A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Pancreatic Ductal Adenocarcinoma
Related studies linked through entity extraction aliases.
Study of Lonsurf in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Advanced (PDAC)
- Status
- TERMINATED
- Phase
- PHASE1
A Study of SGN-CD228A in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers
- Status
- TERMINATED
- Phase
- PHASE1
Study Evaluating NEOadjuvant Immunotherapy in Resectable PANCreatic Ductal Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Impact of Multidisciplinary and Radiologic Review on Outcome of Pancreatic Cancer Patients: an Observational Study
- Status
- COMPLETED
- Phase
- N/A
Volumetric Laser Endomicroscopy's (VLE) Diagnostic Accuracy Validation Study: Impact on Clinical Management Study
- Status
- UNKNOWN
- Phase
- N/A
Nab-Paclitaxel + Cisplatin + Gemcitabine in Untreated Metastatic Pancreatic Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Phase 1 Study of LCAR-C182A Cells in the Treatment of Advanced Gastric Cancer and Pancreatic Ductal Adenocarcinoma
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Pilot Study of a Multimodal Prehabilitation Pancreatic Cancer Program
- Status
- UNKNOWN
- Phase
- NA
Evaluation of MRI Sequences for Ultra-rapid Acquisition of Bile Ducts Images
- Status
- TERMINATED
- Phase
- NA
CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy
- Status
- COMPLETED
- Phase
- PHASE1
High Resolution Ultrasound in Pancreatic Ductal Adenocarcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
OSE2101+FOLFIRI, or FOLFIRI Maintenance After FOLFIRINOX-based Induction Therapy in Advanced or Metastatic PDAC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Personalized Neoantigen Cancer Vaccines
- Status
- COMPLETED
- Phase
- N/A
Study of the Effect of Prehabilitation on Markers of Sarcopenia in Patients Undergoing Pancreatoduodenectomy for Malignant Disease
- Status
- COMPLETED
- Phase
- N/A
Trial of Neoadjuvant and Adjuvant Nivolumab and BMS-813160 With or Without GVAX for Locally Advanced Pancreatic Ductal Adenocarcinomas.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Pembrolizumab With or Without Defactinib Following Chemotherapy as a Neoadjuvant and Adjuvant Treatment for Resectable Pancreatic Ductal Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2